Blog
RSS FeedPosted by Michael Wonder on 13 Feb 2018
Statement from FDA Commissioner Scott Gottlieb on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition
13 February 2018 - Additional resources will help advance initiatives to support novel medical technology and public health priorities such as ...
Posted by Michael Wonder on 13 Feb 2018
Pharma gets the worst of both drug pricing worlds
14 February 2018 - Growth is slowing dramatically, but the political pressure isn't. ...
Posted by Michael Wonder on 06 Feb 2018
AusBiotech says plan to disadvantage life sciences innovation
6 February 2018 - Response to Innovation and Science Australia 2030 plan. ...
Posted by Michael Wonder on 05 Feb 2018
Standard deviation and standard error: interpretation, usage and reporting
5 February 2018 - Standard deviations and standard errors are reported routinely in statistical analyses, but the distinction between them is ...
Posted by Michael Wonder on 31 Jan 2018
How to better apply the paediatric legislation to boost development of medicines for children
31 January 2018 - EMA and European Commission invite stakeholders to register for joint workshop and support development of an ...
Posted by Michael Wonder on 31 Jan 2018
Industry needs clarity to invest in Australia
31 January 2018 - Medicines Australia welcomes the release of the 2030 plan by Innovation and Science Australia but seeks ...
Posted by Michael Wonder on 29 Jan 2018
Medicines Australia welcomes LSDP review outcomes
28 January 2018 - Medicines Australia welcomes the Government’s announcement of an outcome from the post-market review of the Life ...
Posted by Michael Wonder on 24 Jan 2018
PhRMA launches new consumer-facing Let's Talk About Cost website
24 January 2018 - Today, as part of the Let's Talk About Cost campaign, PhRMA launched LetsTalkAboutCost.org, a national consumer-facing ...
Posted by Michael Wonder on 24 Jan 2018
How excluding some benefits from value assessment of new drugs impacts innovation
23 January 2018 - Payers often assess the benefits of new drugs relative to costs for reimbursement purposes, but they frequently ...
Posted by Michael Wonder on 23 Jan 2018
Competition in pharmaceuticals: more product- than price-oriented?
23 January 2018 - Competition is a subject always open to debate in health care, and pharmaceuticals are no exception, with ...
Posted by Michael Wonder on 23 Jan 2018
EMA surveys pharma companies on their preparedness for Brexit
23 January 2018 - Planning of regulatory steps needed to ensure medicines remain on EU market. ...
Posted by Michael Wonder on 18 Jan 2018
Fed up with drug companies, hospitals decide to start their own
18 January 2018 - A group of large hospital systems plans to create a non-profit generic drug company to battle ...
Posted by Michael Wonder on 12 Jan 2018
Pharma collaborates to improve chances of NICE backing Duchenne drugs
11 January 2018 - A group of pharma companies and Duchenne UK are collaborating to improve the chances of new ...
Posted by Michael Wonder on 05 Jan 2018
Made in China: new and potentially lifesaving drugs
3 January 2018 - One new drug promises to stop cancer from spreading to other organs. Another would treat blood ...
Posted by Michael Wonder on 04 Jan 2018
Several drug makers just raised their prices by nearly 10 percent, and buyers expect more price hikes
2 January 2018 - Several drug makers celebrated the new year with substantial single-digit price hikes, while a new survey ...